R&D Q4 Clinical trials round-up: October to December 2025 We round up the key data and innovations in Q4 2025 - and what these likely presage for 2026’s R&D focus.
Oncology Chimeric antigen receptor T-cells: Emerging uses and future ... Genetic engineering technologies allow for the creation of custom-made cells that can have transformative effects on human health.
News Hope for lupus sufferers with Feinstein Institutes-led phase... Findings from the litifilimab trial, undertaken by Northwell Health’s Division of Rheumatology and The Feinstein Institutes for Medical Research, have been published in the New England
Events Partner Content Welcome to the 6th Complement-based Drug Development Summit ... Decipher Complement Pathway Intricacies, Validate Pathway Activation Assays & Discover Next-Generation Complement-Targeted Approaches that are
Events Partner Content 2nd Integrin-Targeted Drug Development Summit In collaboration with leading integrin drug developers, including Genentech, 7 Hills Pharm
Events Partner Content 3rd B & T Cell-Mediated Autoimmune Disease Drug Development ... Industry-led forum focused on B & T Cell Collaboration
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
